Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: Differential glial expression of TGF-β1, 2 and 3 isotypes in multiple sclerosis

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 115-123

  Peress, Nancy S ^b   Perillo, Edward ^b   Seidman, Roberta J ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

glial TGF isotypes; multiple sclerosis; transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; DEMYELINATION; HUMAN; HUMAN TISSUE; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

HUMANS; IMMUNOENZYME TECHNIQUES; MULTIPLE SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0142026496     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00135-X     Document Type: Article

References (63)

1. Allen, I.V. and Kirk, J. (1992) Demyelinating diseases. In: J.H. Adams and L.W. Duchen (Eds.) Greenfield's Neuropathology. Oxford University Press, 1992, pp. 462-482.
2. Branum S.R., Jones J.L. Transforming growth factor β1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes. J. Immunol. 152:1994;765-773.
3. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of Multiple Sclerosis lesions. Ann. Neurol. 37:1995;424-435.
4. Constam D.B., Philipp J., Malipiero U.V., tenDijke P., Schachner M., Fontana A. Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells, astrocytes, and microglia. J. Immunol. 148:1992;1404-1410.
5. Correale J., Gilmore W., McMillan M., Li S., McCathy K., Le T., Weimer L.P. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 154:1995;2959-2968.
6. Czarniecki C.W., Chiu H.H., Wong G.H.W., McCabe S.M., Palladino M.A. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140:1988;4217.
7. daCunha A., Vitkovic L. Transforming growth factor-beta 1 (TGF-β1) expression and regulation in rat cortical astrocytes. J. Neuroimmunol. 36:1992;157-169.
8. Danielpour D., Dart L.L., Flanders K.C., Roberts A.B., Sporn M.B. Immunodetection and quantitation of the two forms of transforming growth factor-Beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell Physiol. 138:1989;79-86.
9. Denhardt F.T., Terz B., Edwards D.R. Tissue inhibition of metalloproteinases (TIMP, aka EPA) structure, control of expressions and biological functions. Pharmacol. Ther. 59:1993;329-341.
10. Dore-Duffy P., Balabanov R., Washington R., Swanborg R.H. Transforming growth factor β1 inhibits cytokine-induced CNS endothelial cell activation. Mol. Chem. Neuropathol. 22:1994;161-175.
11. Esiri, M.M. and Kennedy, P.G.E. (1992) Virus diseases. In: J.H. Adams and L.W. Duchen (Eds.), Greenfield's Neuropathology. Oxford University Press, New York, pp. 367-370.
12. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., Pasinetti G.M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell Biochem. 53:1993;314-322.
13. Flanders K.C., Lippa C.F., Smith T.W., Pollen D.A., Sporn M.B. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology. 45:1995;1561-1569.
14. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immune effector cells of the brain (review). Brain Res. Rev. 20:1995;269-287.
15. Geiser A.G., Busam K.J., Kim S.J., Lafyatis R., O'Reilly M.A., Webbink R., Roberts A.B., Sporn M.B. Regulation of the transforming growth factor-beta 1 and beta 3 promoters by transcription factor Spl. Gene. 129:1993;223-228.
16. Gilbert R.S., Herschman H.R. Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem. Biophys. Res. Commun. 195:1993;380-384.
17. Gottschall P.E., Yu X. Cytokines regulate gelatinase A and B (Matrix Metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 64:1995;1513-1520.
18. Hunter K.E., Sporn M.B., Davies A.M. Transforming growth factor-βs inhibit mitogen stimulated proliferation of astrocytes. Glia. 7:1993;203-211.
19. Johns L.D., Flanders K.C., Ranges G.E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147:1991;1792-1796.
20. Johns L.D., Sriram S. Experimental allergic encephalomyelitis: Neutralizing antibody to TGF-β1 enhances the clinical severity of the disease. J. Neuroimmunol. 47:1993;1-8.
21. Jordan F.L., Thomas W.E. Brain macrophages: Questions of origin and interrelationship. Brain Res. Rev. 13:1988;165-178.
22. Kalaria R.N. The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol. 3:1993;333-347.
23. Kiefer R., Gold R., Gehrmann J., Lindholm D., Wekerle H., Kreutzberg G.W. Transforming growth beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J. Neurosci. Res. 36:1993;391-398.
24. Kiefer R., Streit W.J., Toyka K.V., Kreutzberg G.W., Hartung H.P. Transforming growth factor β-1: A lesion associated cytokine of the nervous system. Int. J. Dev. Neurosci. 13:1995;331-339.
25. Krieglstein K., Rufer M., Suter-Crazzolara C., Unsicker K. Neural functions of the transforming growth factors β Int. J. Dev. Neurosci. 13:1995;301-315.
26. Kulkarni A.B., Ward J.M., Yaswen L., Mackall C.L., Bauer S.R., Huh C., Gress R.E., Karlsson S. Transforming Growth Factor-β1 Null Mice. An animal model for inflammatory disorders. Am. J. Pathol. 146:1995;264-275.
27. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M.A., Thorbecke G.J. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. 88:1991;2918-2921.
28. Laping N.J., Morgan T.E., Nichols N.R., Rozovsky I., Young-Chan C.S., Zarow C., Finch C.E. Transforming growth factor-β1 induces neuronal and astrocyte genes: Tubulin alpha 1, glial fibrillary acidic protein and clusterin. Neuroscience. 58:1994;563-572.
29. Lindholm D., Castren E., Keifer R., Zafra F., Thoenen H. Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117:1992;395-400.
30. Link J., Soderstrom M., Kostulas V., Olsson T., Hojeberg B., Ljungdahl A., Link H. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta. J. Neuroimmunol. 49:1994;9-18.
31. Link J., Soderstrom M., Olsson T., Hojeferg B., Ljungdahl A., Link H. Increased transforming growth factor-β, interleukin-4, and interferon-gamma in multiple sclerosis. Ann. Neurol. 36:1994;379-386.
32. Link J., Fredrikson S., Soderstrom M., Olsson T., Hojeberg B., Ljungdahl A., Link H. Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann. Neurol. 35:1994;197-203.
33. Link J., He B., Navikas V., Palasik W., Fredrikson S., Soderstrom M., Link H. Transforming growth factor-β1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis. J. Neuroimmunol. 58:1995;21-35.
34. Logan A., Frautschy S.A., Gonzalez A.M., Sporn M., Baird A. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cererbral injury. Brain Res. 587:1992;216-225.
35. Logan G.R., Schnitt S.J., Dvorak A.M. Methods in laboratory investigation. Rapid microwave fixation of human tissues for light microscopic immunoperoxidase identification of diagnostically useful antigens. Lab. Invest. 57:1987;585-591.
36. Mattiace L.A., Davies P., Dickson D.W. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am. J. Pathol. 136:1990;1101-1104.
37. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J. Cell Biochem. 53:1993;288-295.
38. May P.C., Finch C.E. Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci. 15:1992;391-396.
39. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:1989;516-527.
40. McKinnon R.D., Piras G., Ida J.A., Dubois-Dalcq M. A role for TGF-β in oligodendrocyte differentiation. J. Cell Biol. 121:1993;1397-1407.
41. Merrill J.E., Zimmerman R.P. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFβ Glia. 4:1991;327-331.
42. Mokhtarian F., Shi Y., Shirazian K., Morgante L., Miller A., Grob K. Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis. J. Immunol. 152:1994;6003-6010.
43. Noble P.W., Henson P.M., Lucas C., Mora-Worms M., Carre P.C., Riches D.W.H. Transforming growth factor-β primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J. Immunol. 151:1993;979-989.
44. Pelton R.W., Saxena B., Jones M., Moses H.L., Gold L.I. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115:1991;1091-1105.
45. Peress N.S., Perillo E. TGF-β2 and TGF-β3 immunoreactivity within the ciliary epithelium. Invest. Ophthalmol. Vis. Sci. 35:1994;453-457.
46. Peress N.S., Perillo E. Differential expression of TGF-Beta 1, 2 and 3 Isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54:1995;802-811.
47. Perry V.H., Mryazak M.K., Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia. 7:1993;60-67.
48. Racke M.K., Cannella B., Albert P., Sporn M., Raine C.S., McFarlin D.E. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int. Immunol. 4(5):1992;615-620.
49. Racke M.K., Dhib-Jalbut S., Cannella B., Albert P.S., Raine C.S., McFarlin D.E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146:1991;3012-3017.
50. Roberts, A.B. and Sporn, M.B. (1990) The transforming growth factor-βs. In: M.B. Sporn and A.B. Roberts (Eds.), Growth Factors and their Receptors: Handbook of Experimental Pharmacology. Springer-Verlag, Heidelberg, pp. 419-472.
51. Roberts A.B., Sporn M.B. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. (Review). Mol. Reprod. Dev. 32:1992;91-98.
52. Rus H.G., Kim L.M., Niculescu F.I., Shin M.L. Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J. Immunol. 148:1992;928-933.
53. Saad B., Constan D.B., Ortmann R., Moos M., Fontana A., Schachner M. Astrocyte derived TGF-β2 and NGF differentially regulate neuronal recognition molecule expression by cultured astrocytes. J. Cell Biol. 115:1991;473-484.
54. Santambrogio L., Hochwald G.M., Saxena B., Leu C., Martz J.E., Carlino J.A., Ruddle N.H., Palladino M.A., Gold L.I., Thorbecke G.J. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. Antagonism between TGF-β and tumor necrosis factor. J. Immunol. 151:1993;1116-1127.
55. Sawada M., Suzumura A., Marunouchi T. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int. J. Dev. Neurosci. 13:1995;253-264.
56. Suzumura A., Sawada M., Yamamoto H., Marunouchi T. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J. Immunol. 151:1993;2150-2158.
57. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-β Nature. 334:1988;260-262.
58. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
59. Wahl S.M., Hunt D.A., Wakefield N., McCartney-Francis L., Wahl M., Roberts A.B., Sporn M.S. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:1987;5788.
60. Weinberg A.D., Whitham R., Swain S.L., Morrison W.J., Wyrick G., Hoy C., Vandenbark A.A., Offner H. Transforming growth factor-β enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J. Immunol. 148:1992;2109-2117.
61. Welch G.R., Wong H.L., Wahl S.M. Selective induction of FcyRIII on human monocytes by transforming growth factor-β J. Immunol. 144:1990;3444-3448.
62. Woodroofe M.N., Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine. 5:1993;583-588.
63. Yamamoto T., Hirano A.A. A comparative study of modified Bielschowsky, Bodian and Thioflavin stains on Alzheimer's neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 12:1986;3-9.